Table 7.

Correlation analysis

Variable 1	Variable 2
	Change in body weight from baseline to week 24			Change in HbA1c from baseline to week 24
	n	ρ (95% CI)	p value	n	ρ (95% CI)	p value
Improvement in “overall quality of life” domain of SHIELD-WQ-9 at week 24	225	− 0.29 (− 0.40, − 0.16)	< 0.001	218	− 0.20 (− 0.33, − 0.07)	0.003
Improvement in “physical health” domain of SHIELD-WQ-9 at week 24	225	− 0.39 (− 0.50, − 0.27)	< 0.001	218	− 0.20 (− 0.32, − 0.06)	0.004
Change in DTR-QOL total score from baseline to week 24	222	− 0.17 (− 0.29, − 0.04)	0.012	216	− 0.21 (− 0.34, − 0.08)	0.001
Change in EQ-5D-5L score from baseline to week 24	224	− 0.11 (− 0.24, 0.02)	0.10	218	− 0.03 (− 0.16, 0.10)	0.64

Data are represented as Spearman's rank correlation coefficient (ρ) and 95% confidence interval (CI)

DTR-QOL Diabetes Therapy-Related Quality of Life, EQ-5D-5L EuroQol five-dimensional five-level version, SHIELD-WQ-9 Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes Weight Questionnaire-9